Natural killer cell deficiencies and severe varicella infection

Journal of Pediatrics

Volumn 148, Issue 4, 2006, Pages 563-

  Zimmer, Jacques ^a   Hentges, François ^a   Andrès, Emmanuel ^b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FUNCTION; CONDYLOMA; CYTOTOXICITY; DISEASE SEVERITY; HERPES ZOSTER; HUMAN; LETTER; NATURAL KILLER CELL; PRIORITY JOURNAL; CHICKENPOX; FEMALE; IMMUNOLOGY; LYMPHOCYTOPENIA; NOTE; PATHOPHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

CHICKENPOX; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOPENIA; T-LYMPHOCYTE SUBSETS;

EID: 33646115205     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.06.029     Document Type: Letter

References (9)

1. Etzioni A., Eidenschenk C., Katz R., Beck R., Casanova J.L., and Pollack S. Fatal varicella associated with selective natural killer cell deficiency. J Pediatr 146 (2005) 423-425
2. Biron C.A., Byron K.S., and Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320 (1989) 1731-1735
3. Ballas Z.K., Turner J.M., Turner D.A., Goetzmann E.A., and Kemp J.D. A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset. J Allergy Clin Immunol 85 (1990) 453-459
4. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 9 (1997) 24-34
5. Orange J.S., Brodeur S.R., Jain A., Bonilla F.A., Schneider L.C., Kretschmer R., et al. Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations. J Clin Invest 109 (2002) 1501-1509
6. de la Salle H., Hanau D., Fricker D., Urlacher A., Kelly A., Salamero J., et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265 (1994) 237-241
7. Zimmer J., Donato L., Hanau D., Cazenave J.P., Tongio M.M., Moretta A., et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med 187 (1998) 117-122
8. Furukawa H., Yabe T., Watanabe K., Miyamoto R., Miki A., Akaza T., et al. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum Immunol 60 (1999) 32-40
9. Levy O., Orange J.S., Hibberd P., Steinberg S., LaRussa P., Weinberg A., et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis 188 (2003) 948-953